(and dosage form):
Each tablet contains:
Each tablet digests (in vitro):
|| 6 500 N.F. |
|| 32 000 N.F. |
|| 48 000 N.F.|
|| 23 g|
|| 32 g|
|| 48 g|
A 31 Enzymatic Preparations.
Each tablet contains sufficient pancreatic enzymes to digest, in vitro, 32 grams of dietary protein, 48 grams of dietary starch, and 23 grams of dietary fat. Viokase is used as a digestive aid and in the treatment of pancreatic insufficiency. Viokase contains less than 1% of fat and is not enteric coated.
Pancreatic insufficiency associated with Cystic Fibrosis, pancreatitis, post-gastrectomy, post-cholecystectomy, post-pancreatectomy. Viokase is helpful in functional dyspepsias.
DOSAGE AND DIRECTIONS FOR USE:
Patients with cystic fibrosis or chronic pancreatitis:
1 to 3 tablets with meals.
For aiding digestion in patients with pancreatectomy or gastrectomy:
1 to 2 tablets taken at 2 hour intervals, or as directed by a physician.
SIDE-EFFECTS AND SPECIAL PRECAUTIONS:
None. Use with caution in patients known to be allergic to pork protein.
Viokase is a white to cream biconvex uncoated tablet, mottled with brown spots. It is embossed with "CE" on the one side.
Bottles of 100 and 500 tablets.
Store below 25°C in well-closed container.
Protect from light and moisture.
KEEP OUT OF REACH OF CHILDREN.
H2870 (Act 101/1965).
NAME AND BUSINESS ADDRESS OF APPLICANT:
7 Fairclough Road
Port Elizabeth 6001
DATE OF PUBLICATION OF THIS PACKAGE INSERT:
A & S PRINTERS
Updated on this site November 1999
Current: March 2005
Source: Hospital Pharmacy
SAEPI HOME PAGE
TRADE NAME INDEX
GENERIC NAME INDEX
Information presented by Malahyde Information Systems © Copyright 1996-2005